866-997-4948(US-Canada Toll Free)

Biotechnology: RNAi

Published By :

RI Technologies

Published Date : May 2014

Category :

No. of Pages : 1147 Pages

The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- North America, Europe, Asia-Pacific and Rest of World. 

The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, miRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and Electroporation), Monitoring/Optimizing (Primers for RTqPCR, Controls, and miRNA Detection Tools), and Libraries (Human, Mouse, and Rat). 

Application by Research (Functional Genomics, Metabolism, and Protein Chemistry), Therapeutics (Oncology, Neurology, Ophthalmology, and Virology) and Drug Development (Target Identification, Target Validation, and Drug Mechanism) are also analyzed. 

Business profiles of 26 major companies are discussed in the report. 

The report serves as a guide to global RNAi industry, as it covers more than 350 companies that are engaged in RNAi R&D, discovery, testing and supply of products and services. 

Major Contract Research Organizations serving RNAi industry are also covered in the Corporate Directory section of this report. 

Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. 

Estimations and predictions are provided by geographic region with exclusive graphical representations illustrated for 476 exhibits.
Table of Content

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS
2.1 Introduction to RNAi
RNAi - Nature’s Way of Silencing Gene
Definition
Summary
RNAi – The Main Objectives of Our Study
RNAi – Some Basics
History of RNAi
RNAi – Origins and Discovery
2.2 Segmentation of RNAi
Exhibit 1. Segmentation of Global RNAi Market by Application and Tools/Products
Exhibit 2. Segmentation by Application
Exhibit 3. Segmentation by Tools/Products
Facts About RNAi
Relation between siRNA Length and siRNA Function
Functional Significance of siRNA Length
Is siRNA Length Influential of siRNA Function?
Use of RNAi in Mammalian Systems
2.3 RNAi - Global Market Analysis
Exhibit 4. RNAi– Global Market Estimations & Predictions (2005 -2020) in US$ Million (Graphical Representation Included)
Exhibit 5. List of Major RNAi Global Companies

3. MARKET DYNAMICS
3.1 Global RNAi Market Overview
RNAi - A Breakthrough in Molecular Biology
Nobel Prize
RNAi – Gene Silencing Mechanism
esiRNA Technology
RNAi – The Corporate Scenario
RNAi – The Commercial Potential
RNAi – The Pharma Perspective
RNAi – Unlike Stem Cell Therapy
Global RNAi Market
Exhibit 6. RNAi – Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 7. RNAi – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.2 North America RNAi Market
Exhibit 8. RNAi – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 9. RNAi – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.2 (i) United States RNAi Market
Exhibit 10. List of Major United States RNAi Companies
3.2 (ii) Canadian RNAi Market
Exhibit 11. List of Major Candian RNAi Companies
3.3 European RNAi Market
Exhibit 12. RNAi – European Market Estimations & Predictions (2005 - 2020) by Geographic Region for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 13. RNAi – EuropeanMarket Shares (2010, 2015 & 2020) by Geographic Region for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.3 (i) German RNAi Market
3.3 (ii) United Kingdom RNAi Market
3.3 (iv) Belgian RNAi Market
3.3 (v) French RNAi Market
3.3 (vi) Russian RNAi Market
Exhibit 14. List of Major European RNAi Companies
3.4 Asia-Pacific RNAi Market
Exhibit 15. RNAi –Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 16. RNAi – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.4 (i) Australian RNAi Market
3.4 (ii) Japanese RNAi Market
3.4 (iii) China RNAi Market
3.4 (iv) Indian RNAi Market
3.4 (v) South Korean RNAi Market
Exhibit 17. List of Major Asia-Pacific RNAi Companies
3.5 Rest of World RNAi Market
Exhibit 18. RNAi – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 19. RNAi – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
3.5 (i) Brazilian RNAi Market
3.5 (ii) Israeli RNAi Market
3.5 (iii) South African RNAi Market
Exhibit 20. List of Major Rest of World RNAi Companies
3.6 RNAi - Market Trends
RNAi – An Emerging Class of Drugs in Pharmaceuticals
Biotech/Pharma Industry’s Interest in RNAi
RNAi’s Functionality
Sourcing and Market Potential
Marketing Strategy
Economic Possibilities
The Mission Ahead for RNAi
More…
3.7 RNA interference (RNAi)
Introduction
Redefinition of RNA
Knockdown of Genes
RNAi on a Large Scale
RNAi: Beyond Machinery
Silencing Diseases
Principle Behind RNAi
Delivery
Area of Concern
3.8 Major Companies in RNAi Industry
Allele Biotechnology and Pharmaceuticals, Inc. (USA)
Alnylam Pharmaceuticals, Inc. (USA)
Antisense Therapeutics Limited (Australia)
Arrowhead Research Corporation (USA)
Asuragen, Inc. (USA)
Benitec Ltd. (Australia)
More…
3.9 Major Activities in RNAi Market
Benitec Biopharma Out-Licenses RNAi Technology to Regen
Arcturus Therapeutic Takes Over Marina’s UNA Patent Estate
Thermo Fisher Scientific Plans to Acquire Life Technologies Corporation
Medicines Company Enters into a RNAi Therapeutics Partnership with Alnylam
Santaris Pharma A/S and miRagen Therapeutics Expands Global Strategic Partnership
Benitec Acquires Tacere Therapeutics
Syngenta Acquires Devgen
More…
3.10 Major Product Innovations/Launches in RNAi Market
Israeli Office of the Chief Scientist Funds Rosetta Genomics and Ramot Tel Aviv University’s Development of microRNA Oncology Therapy
Alnylam Attains Additional Orphan Drug Status for ALN-AT3, an RNAi Therapeutic from U.S. FDA for the Treatment of Hemophilia
Arrowhead Initiates Phase I Trial of RNAi Therapeutic - ARC-520 for Chronic Hepatitis B Infection Treatment
Alnylam Releases Positive Superior Outcome for ALN-TTRsc for Treating TTR-Mediated Amyloidosis
Dicerna Added Patent Claims Widening Coverage of Extended Dicer Substrate Therapeutic Structures
Alnylam Releases Novel Pre-clinical Data on ALN-AT3, for the Treatment of Hemophilia and Rare Bleeding Disorders
More…
3.11 Analysis by Application
Exhibit 21. RNAi Applications – Global Market Estimations & Predictions (2005 -2020) by Type for Research, Therapeutics, Drug Development and Other in US$ Million (Graphical Representation Included)
Exhibit 22. RNAi Applications - Global Market Shares (2010, 2015 & 2020) by Type for Research, Therapeutics, Drug Development and Other (Graphical Representation Included)
3.11.1 RNAi in Research
3.11.1.1 Global Market for RNAi in Research
Exhibit 23. RNAi in Research - Global Market Estimations & Predictions (2005 - 2020) by Application for Functional Genomics, Protein Chemistry, Metabolism and Other in US$ Million (Graphical Representation Included)
Exhibit 24. RNAi in Research - Global Market Shares (2010, 2015 & 2020) by Application for Functional Genomics, Protein Chemistry, Metabolism and Other (Graphical Representation Included)
Exhibit 25. RNAi in Research - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 26. RNAi in Research - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
Exhibit 27. List of Global RNAi Companies in Research
3.11.1.2 North American Market for RNAi in Research
Exhibit 28. RNAi in Research – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 29. RNAi in Research – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.11.1.3 European Market for RNAi in Research
Exhibit 30. RNAi in Research - European Market Estimations & Predictions (2005 - 2020)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 31. RNAi in Research - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.11.1.4 Asia-Pacific Market for RNAi in Research
Exhibit 32. RNAi in Research - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 33. RNAi in Research – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.11.1.5 Rest of World Market for RNAi in Research
Exhibit 34. RNAi in Research – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 35. RNAi in Research – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
3.11.2 RNAi in Functional Genomics
3.11.2.1 Global Market for RNAi in Functional Genomics
Exhibit 36. RNAi in Functional Genomics – Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 37. RNAi in Functional Genomics – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.2.2 North American Market for RNAi in Functional Genomics
Exhibit 38. RNAi in Functional Genomics – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 39. RNAi in Functional Genomics – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.11.2.3 European Market for RNAi in Functional Genomics
Exhibit 40. RNAi in Functional Genomics- European Market Estimations & Predictions (2005 - 2020)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 41. RNAi in Functional Genomics - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.11.2.4 Asia-Pacific Market for RNAi in Functional Genomics
Exhibit 42. RNAi in Functional Genomics- Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 43. RNAi in Functional Genomics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.11.2.5 Rest of World Market for RNAi in Functional Genomics
Exhibit 44. RNAi in Functional Genomics – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 45. RNAi in Functional Genomics – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
3.11.3 RNAi in Protein Chemistry
3.11.3.1 Global Market for RNAi in Protein Chemistry
Exhibit 46. RNAi in Protein Chemistry– Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 47. RNAi in Protein Chemistry – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.3.2 North American Market for RNAi in Protein Chemistry
Exhibit 48. RNAi in Protein Chemistry – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 49. RNAi in Protein Chemistry – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.11.3.3 European Market for RNAi in Protein Chemistry
Exhibit 50. RNAi in Protein Chemistry - European Market Estimations & Predictions (2005 - 2020)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 51. RNAi in Protein Chemistry - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.11.3.4 Asia-Pacific Market for RNAi in Protein Chemistry
Exhibit 52. RNAi in Protein Chemistry- Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 53. RNAi in Protein Chemistry – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.11.3.5 Rest of World Market for RNAi in Protein Chemistry
Exhibit 54. RNAi in Protein Chemistry – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 55. RNAi in Protein Chemistry – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
3.11.4 RNAi in Metabolism
3.11.4.1 Global Market for RNAi in Metabolism
Exhibit 56. RNAi in Metabolism– Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 57. RNAi in Metabolism – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.4.2 North American Market for RNAi in Metabolism
Exhibit 58. RNAi in Metabolism – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 59. RNAi in Metabolism – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.11.4.3 European Market for RNAi in Metabolism
Exhibit 60. RNAi in Metabolism - European Market Estimations & Predictions (2005 - 2020)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 61. RNAi in Metabolism - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.11.4.4 Asia-Pacific Market for RNAi in Metabolism
Exhibit 62. RNAi in Metabolism- Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 63. RNAi in Metabolism – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.11.4.5 Rest of World Market for RNAi in Metabolism
Exhibit 64. RNAi in Metabolism – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 65. RNAi in Metabolism – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
3.11.5 RNAi in Other Research Applications
3.11.5.1 Global Market for RNAi in Other Research Applications
Exhibit 66. RNAi in Other Research Applications – Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 67. RNAi in Other Research Applications – Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.11.5.2 North American Market for RNAi in Other Research Applications
Exhibit 68. RNAi in Other Research Applications – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 69. RNAi in Other Research Applications – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.11.5.3 European Market for RNAi in Other Research Applications
Exhibit 70. RNAi in Other Research Applications - European Market Estimations & Predictions (2005 - 2020)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 71. RNAi in Other Research Applications - European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.11.5.4 Asia-Pacific Market for RNAi in Other Research Applications
Exhibit 72. RNAi in Other Research Applications- Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 73. RNAi in Other Research Applications – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.11.5.5 Rest of World Market for RNAi in Other Research Applications
Exhibit 74. RNAi in Other Research Applications – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 75. RNAi in Other Research Applications – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
3.12 RNAi Therapeutics
Exhibit 76. RNAi Therapeutics - Global Market Estimations & Predictions (2005 - 2020) by Application for Ophthalmology, Virology, Neurology, Oncology and Other in US$ Million (Graphical Representation Included)
Exhibit 77. RNAi Therapeutics - Global Market Shares (2010, 2015 & 2020) by Application for Ophthalmology, Virology, Neurology, Oncology and Other (Graphical Representation Included)
Exhibit 78. List of Global RNAi based Therapeutics Companies
Exhibit 79. Drug Development Status of RNAi based Therapeutics
3.12.1 Global Market for RNAi Therapeutics
Exhibit 80. RNAi Therapeutics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 81. RNAi Therapeutics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.12.1.1 North American Market for RNAi Therapeutics
Exhibit 82. RNAi Therapeutics – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 83. RNAi Therapeutics – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
United States Market for RNAi Therapeutics
Canadian Market for RNAi Therapeutics
3.12.1.2 European Market for RNAi Therapeutics
Exhibit 84. RNAi Therapeutics -European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 85. RNAi Therapeutics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
German Market for RNAi Therapeutics
United Kingdom Market for RNAi Therapeutics
Belgian Market for RNAi Therapeutics
French Market for RNAi Therapeutics
Russian Market for RNAi Therapeutics
3.12.1.3 Asia-Pacific Market for RNAi Therapeutics
Exhibit 86. RNAi Therapeutics - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 87. RNAi Therapeutics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Australian Market for RNAi Therapeutics
Japanese Market for RNAi Therapeutics
Chinese Market for RNAi Therapeutics
Indian Market for RNAi Therapeutics
South Korean Market for RNAi Therapeutics
3.12.1.4 Rest of World Market for RNAi Therapeutics
Exhibit 88. RNAi Therapeutics – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 89. RNAi Therapeutics – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Brazilian RNAi Therapeutics Market
Israeli RNAi Therapeutics Market
South African RNAi Therapeutics Market
3.13 RNAi in Ophthalmology
3.13.1 Global Market for RNAi in Ophthalmology
Exhibit 90. RNAi in Ophthalmology - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 91. RNAi in Ophthalmology - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
3.13.2 North American Market for RNAi in Ophthalmology
Exhibit 92. RNAi in Ophthalmology – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 93. RNAi in Ophthalmology – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
3.13.3 European Market for RNAi in Ophthalmology
Exhibit 94. RNAi in Ophthalmology - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 95. RNAi in Ophthalmology – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
3.13.4 Asia-Pacific Market for RNAi in Ophthalmology
Exhibit 96. RNAi in Ophthalmology - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 97. RNAi in Ophthalmology – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
3.13.5 Rest of World Market for RNAi in Ophthalmology
Exhibit 98. RNAi in Ophthalmology – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 99. RNAi in Ophthalmology – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Virology
Global Market for RNAi in Virology
Exhibit 100. RNAi in Virology - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 101. RNAi in Virology - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Virology
Exhibit 102. RNAi in Virology – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 103. RNAi in Virology – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Virology
Exhibit 104. RNAi in Virology - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 105. RNAi in Virology – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Virology
Exhibit 106. RNAi in Virology - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 107. RNAi in Virology – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Virology
Exhibit 108. RNAi in Virology – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 109. RNAi in Virology – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Neurology
Global Market for RNAi in Neurology
Exhibit 110. RNAi in Neurology - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 111. RNAi in Neurology - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Neurology
Exhibit 112. RNAi in Neurology – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 113. RNAi in Neurology – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Neurology
Exhibit 114. RNAi in Neurology -European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 115. RNAi in Neurology – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Neurology
Exhibit 116. RNAi in Neurology - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 117. RNAi in Neurology – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Neurology
Exhibit 118. RNAi in Neurology – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 119. RNAi in Neurology – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Oncology
Global Market for RNAi in Oncology
Exhibit 120. RNAi in Oncology - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 121. RNAi in Oncology - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Oncology
Exhibit 122. RNAi in Oncology – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 123. RNAi in Oncology – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Oncology
Exhibit 124. RNAi in Oncology - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 125. RNAi in Oncology – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Oncology
Exhibit 126. RNAi in Oncology - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 127. RNAi in Oncology – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Oncology
Exhibit 128. RNAi in Oncology – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 129. RNAi in Oncology – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Other RNAi Therapeutics
Global Market for Other RNAi Therapeutics
Exhibit 130. Other RNAi Therapeutics - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 131. Other RNAi Therapeutics - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for Other RNAi Therapeutics
Exhibit 132. Other RNAi Therapeutics – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 133. Other RNAi Therapeutics – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for Other RNAi Therapeutics
Exhibit 134. Other RNAi Therapeutics - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 135. Other RNAi Therapeutics – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for Other RNAi Therapeutics
Exhibit 136. Other RNAi Therapeutics - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 137. Other RNAi Therapeutics – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for Other RNAi Therapeutics
Exhibit 138. Other RNAi Therapeutics – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 139. Other RNAi Therapeutics – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Drug Development
Exhibit 140. RNAi in Drug Development - Global Market Estimations & Predictions (2005 - 2020) by Application for Target Validation, Target Identification, Drug Mechanism and Other in US$ Million (Graphical Representation Included)
Exhibit 141. RNAi in Drug Development - Global Market Shares (2010, 2015 & 2020) by Application for Target Validation, Target Identification, Drug Mechanism and Other (Graphical Representation Included)
Global Market for RNAi in Drug Development
Exhibit 142. RNAi in Drug Development - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 143. RNAi in Drug Development - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Drug Development
Exhibit 144. RNAi in Drug Development – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 145. RNAi in Drug Development – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
United States RNAi in Drug Development Market
Canadian RNAi in Drug Development Market
European Market for RNAi in Drug Development
Exhibit 146. RNAi in Drug Development - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 147. RNAi in Drug Development– European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
German RNAi in Drug Development Market
United Kingdom RNAi in Drug Development Market
Belgian RNAi in Drug Development Market
France RNAi in Drug Development Market
Russian RNAi in Drug Development Market
Asia-Pacific Market for RNAi in Drug Development
Exhibit 148. RNAi in Drug Development - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 149. RNAi in Drug Development– Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Australian RNAi in Drug Development Market
Japan RNAi in Drug Development Market
Chinese RNAi in Drug Development Market
India RNAi in Drug Development Market
South Korea RNAi in Drug Development Market
Rest of World Market for RNAi in Drug Development
Exhibit 150. RNAi in Drug Development – Rest of Wolrd Market Estimations & Predictions (2005 - 2020) by Country for Brazil , Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 151. RNAi in Drug Development – Rest of Wolrd Market Shares (2010, 2015 & 2020) by Country for Brazil , Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Brazilian RNAi in Drug Development Market
Israel RNAi in Drug Development Market
South Africa RNAi in Drug Development Market
RNAi in Target Validation
Global Market for RNAi in Target Validation
Exhibit 152. RNAi in Target Validation - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 153. RNAi in Target Validation - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Target Validation
Exhibit 154. RNAi in Target Validation – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 155. RNAi in Target Validation – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Target Validation
Exhibit 156. RNAi in Target Validation - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 157. RNAi in Target Validation– European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Target Validation
Exhibit 158. RNAi in Target Validation - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 159. RNAi in Target Validation– Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Target Validation
Exhibit 160. RNAi in Target Validation – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries in US$ Million (Graphical Representation Included)
Exhibit 161. RNAi in Target Validation – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries (Graphical Representation Included)
RNAi in Target Identification
Global Market for RNAi in Target Identification
Exhibit 162. RNAi in Target Identification - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 163. RNAi in Target Identification - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Target Identification
Exhibit 164. RNAi in Target Identification – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 165. RNAi in Target Identification – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Target Identification
Exhibit 166. RNAi in Target Identification - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 167. RNAi in Target Identification– European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Target Identification
Exhibit 168. RNAi in Target Identification - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 169. RNAi in Target Identification– Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Target Identification
Exhibit 170. RNAi in Target Identification – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical
Representation Included)
Exhibit 171. RNAi in Target Identification – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Drug Mechanism
Global Market for RNAi in Drug Mechanism
Exhibit 172. RNAi in Drug Mechanism - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 173. RNAi in Drug Mechanism - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Drug Mechanism
Exhibit 174. RNAi in Drug Metabolism – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 175. RNAi in Drug Metabolism – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Drug Mechanism
Exhibit 176. RNAi in Drug Mechanism - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 177. RNAi in Drug Mechanism– European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Drug Mechanism
Exhibit 178. RNAi in Drug Mechanism - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 179. RNAi in Drug Mechanism– Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Drug Mechanism
Exhibit 180. RNAi in Drug Metabolism – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 181. RNAi in Drug Metabolism – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi in Other Drug Development Applications
Global Market for RNAi in Other Drug Development Applications
Exhibit 182. RNAi in Other Drug Development Applications - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 183. RNAi in Other Drug Development Applications - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for RNAi in Other Drug Development Applications
Exhibit 184. RNAi in Other Drug Development Applications – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 185. RNAi in Other Drug Development Applications – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for RNAi in Other Drug Development Applications
Exhibit 186. RNAi in Other Drug Development Applications - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 187. RNAi in Other Drug Development Applications– European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for RNAi in Other Drug Development Applications
Exhibit 188. RNAi in Other Drug Development Applications - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 189. RNAi in Other Drug Development Applications– Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World Market for RNAi in Other Drug Development Applications
Exhibit 190. RNAi in Other Drug Development Applications – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 191. RNAi in Other Drug Development Applications – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Analysis by Tools/Products
Exhibit 192. RNAi Tools/Products – Global Market Estimations & Predictions (2005 - 2020) by Type for Design/Software, Synthesis, Delivery, Monitoring/Optimizing, Libraries and Other in US$ Million (Graphical Representation Included)
Exhibit 193. RNAi Tools/Products – Global Market Shares (2010, 2015 & 2020) by Type for Design/Software, Synthesis, Delivery, Monitoring/Optimizing, Libraries and Other (Graphical Representation Included)
RNAi Design/Software Market
Exhibit 194. RNAi Design/Software Tools/Products - Global Market Estimations & Predictions (2005 - 2020) by Type for MiRNA Target Scan, MiRNA Analysis Software, Design Algorithm and Other in US$ Million (Graphical Representation Included)
Exhibit 195. RNAi Design/Software Tools/Products - Global Market Shares (2010, 2015 & 2020) by Type for MiRNA Target Scan, MiRNA Analysis Software, Design Algorithm and Other (Graphical Representation Included)
Global RNAi Design/Software Market
Exhibit 196. RNAi Design/Software - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 197. RNAi Design/Software - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American RNAi Design/Software Market
Exhibit 198. RNAi Design/Software – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 199. RNAi Design/Software – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
United States RNAi Design/Software Market
Canadian RNAi Design/Software Market
European RNAi Design/Software Market
Exhibit 200. RNAi Design/Software - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 201. RNAi Design/Software – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
German RNAi Design/Software Market
United Kingdom RNAi Design/Software Market
Belgian RNAi Design/Software Market
French RNAi Design/Software Market
Russian RNAi Design/Software Market
Asia-Pacific RNAi Design/Software Market
Exhibit 202. RNAi Design/Software - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 203. RNAi Design/Software – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Australian RNAi Design/Software Market
Japanese RNAi Design/Software Market
Chinese RNAi Design/Software Market
Indian RNAi Design/Software Market
South Korean RNAi Design/Software Market
Rest of World RNAi Design/Software Market
Exhibit 204.: RNAi Design/Software – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 205.: RNAi Design/Software – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Brazilian RNAi Design/Software Market
Israeli RNAi Design/Software Market
South African RNAi Design/Software Market
MiRNA Target Scan Market
Global MiRNA Target Scan Market
Exhibit 206. MiRNA Target Scan - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 207. MiRNA Target Scan - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American MiRNA Target Scan Market
Exhibit 208. MiRNA Target Scan – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 209. MiRNA Target Scan – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European MiRNA Target Scan Market
Exhibit 210. MiRNA Target Scan - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 211. MiRNA Target Scan – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific MiRNA Target Scan Market
Exhibit 212. MiRNA Target Scan - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 213. MiRNA Target Scan – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World MiRNA Target Scan Market
Exhibit 214. MiRNA Target Scan – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 215. MiRNA Target Scan – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
MiRNA Analysis Software Market
Global MiRNA Analysis Software Market
Exhibit 216. MiRNA Analysis Software - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 217. MiRNA Analysis Software - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American MiRNA Analysis Software Market
Exhibit 218. MiRNA Analysis Software – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 219. MiRNA Analysis Software – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European MiRNA Analysis Software Market
Exhibit 220. MiRNA Analysis Software - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 221. MiRNA Analysis Software – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific MiRNA Analysis Software Market
Exhibit 222. MiRNA Analysis Software - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 223. MiRNA Analysis Software – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World MiRNA Analysis Software Market
Exhibit 224. MiRNA Analysis Software – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 225. MiRNA Analysis Software – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
RNAi Design Algorithm Market
Global RNAi Design Algorithm Market
Exhibit 226. RNAi Design Algorithm - Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 227. RNAi Design Algorithm - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American RNAi Design Algorithm Market
Exhibit 228. RNAi Design Algorithm – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 229. RNAi Design Algorithm – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European RNAi Design Algorithm Market
Exhibit 230. RNAi Design Algorithm - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 231. RNAi Design Algorithm – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific RNAi Design Algorithm Market
Exhibit 232. RNAi Design Algorithm - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 233. RNAi Design Algorithm – Asia-Pacific Market Shares (2010, 2015 & 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific (Graphical Representation Included)
Rest of World RNAi Design Algorithm Market
Exhibit 234. RNAi Design Algorithm – Rest of World Market Estimations & Predictions (2005 - 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Exhibit 235. RNAi Design Algorithm – Rest of World Market Shares (2010, 2015 & 2020) for Brazil, Israel, South Africa and Other Countries US$ Million (Graphical Representation Included)
Other RNAi Design /Softwares
Global Market for Other RNAi Design /Softwares
Exhibit 236. Other RNAi Design /Softwares- Global Market Estimations & Predictions (2005 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
Exhibit 237. Other RNAi Design /Softwares - Global Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
North American Market for Other RNAi Design /Softwares
Exhibit 238. Other RNAi Design /Softwares – North American Market Estimations & Predictions (2005 - 2020) for United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 239. Other RNAi Design /Softwares – North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included)
European Market for Other RNAi Design /Softwares
Exhibit 240. Other RNAi Design /Softwares - European Market Estimations & Predictions (2005 - 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 241. Other RNAi Design /Softwares – European Market Shares (2010, 2015 & 2020) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe (Graphical Representation Included)
Asia-Pacific Market for Other RNAi Design /Softwares
Exhibit 242. Other RNAi Design /Softwares - Asia-Pacific Market Estimations & Predictions (2005 - 2020) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 243. Other RNAi Design /Softwares – Asia-Pacific Market Sh

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *